​

Nexalin Ownership | Who Owns Nexalin?

OverviewRevenueFinancialsChart

Nexalin Ownership Summary

Nexalin is owned by 8.36% institutional investors, 14.34% insiders, and 77.30% retail investors. Myda advisors is the largest institutional shareholder, holding 5.09% of NXL shares.

NXL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNexalin8.36%14.34%77.30%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryMedical Device Stocks52.25%10.55%37.19%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Myda advisors800.00K5.09%$790.24K
Vanguard group125.46K1.16%$346.27K
Geode capital management107.24K0.99%$295.98K
Morgan stanley59.80K0.80%$101.07K
Cvi55.46K0.75%$93.73K
State street16.80K0.23%$28.39K
Xtx topco22.14K0.14%$22.59K
Two sigma securities11.77K0.07%$11.62K
Atria wealth solutions10.35K0.07%$10.22K
Kovack advisors10.05K0.06%$9.93K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Myda advisors800.00K0.14%$790.24K
Cvi55.46K0.08%$93.73K
Two sigma securities11.77K0.00%$11.62K
Kovack advisors10.05K0.00%$9.93K
Xtx topco22.14K0.00%$22.59K
Kingsview wealth management10.00K0.00%$9.88K
Atria wealth solutions10.35K0.00%$10.22K
Ifp advisors---
Renaissance---
Advisor group---

Top Buyers

HolderShares% AssetsChange
Myda advisors800.00K0.14%800.00K
Vanguard group125.46K-93.68K
Morgan stanley59.80K-59.80K
Cvi55.46K0.08%55.46K
Geode capital management107.24K-28.54K

Top Sellers

HolderShares% AssetsChange
Renaissance---102.90K
Susquehanna group, llp---42.38K
Virtu financial---23.45K
Drive wealth management---15.00K
Cetera investment advisers---14.00K

New Positions

HolderShares% AssetsChangeValue
Myda advisors800.00K0.14%800.00K$790.24K
Morgan stanley59.80K-59.80K$101.07K
Cvi55.46K0.08%55.46K$93.73K
State street16.80K-16.80K$28.39K
Two sigma securities11.77K0.00%11.77K$11.62K

Sold Out

HolderChange
Citigroup-1.00
Ubs group-140.00
Spire wealth management-300.00
Stone house investment management-357.00
Wells fargo & company/mn-600.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252123.53%1,314,236230.95%893.89%1385.71%--100.00%
Mar 31, 202517-5.56%397,1166.95%225.47%8-50.00%3200.00%
Dec 31, 20241721.43%339,026-20.83%320.05%1566.67%1-66.67%
Sep 30, 2024147.69%428,24955.02%328.61%9-25.00%3200.00%
Jun 30, 202413160.00%276,263335.29%3510.07%12200.00%1-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 10, 2025Elson Marilyn-Sell$96.07K
Mar 12, 2025Shelton Carolyn Hamby Sr. VP - Quality, RegulatoryBuy$13.20K
Feb 04, 2025Owens David Chief Medical OfficerBuy$3.10K
Feb 04, 2025Owens David Chief Medical OfficerBuy$2.98K
Nov 02, 2024Kazden Alan-Buy$246.75K

Insider Transactions Trends

DateBuySell
2026 Q3--
2025 Q3--
2025 Q16-
2024 Q42-
2024 Q31-

NXL Ownership FAQ

Who Owns Nexalin?

Nexalin shareholders are primarily institutional investors at 8.36%, followed by 14.34% insiders and 77.30% retail investors. The average institutional ownership in Nexalin's industry, Medical Device Stocks, is 52.25%, which Nexalin falls below.

Who owns the most shares of Nexalin?

Nexalin’s largest shareholders are Myda advisors (800K shares, 5.09%), Vanguard group (125.46K shares, 1.16%), and Geode capital management (107.24K shares, 0.99%). Together, they hold 7.23% of Nexalin’s total shares outstanding.

Does Blackrock own Nexalin?

BlackRock is not among the top 10 institutional shareholders of Nexalin.

Who is Nexalin’s biggest shareholder by percentage of total assets invested?

Myda advisors is Nexalin’s biggest shareholder by percentage of total assets invested, with 0.14% of its assets in 800K Nexalin shares, valued at 790.24K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools